Form 8-K - Current report:
SEC Accession No. 0001062822-26-000094
Filing Date
2026-05-06
Accepted
2026-05-06 16:01:41
Documents
12
Period of Report
2026-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20260504.htm   iXBRL 8-K 35179
2 EX-99.1 pressrelease05-06x2026.htm EX-99.1 11224
  Complete submission text file 0001062822-26-000094.txt   168850

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20260504.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20260504_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20260504_pre.xml EX-101.PRE 12512
16 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20260504_htm.xml XML 3105
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 26948153
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)